Full coverage: Multinationals

Already the dominating player in Ireland’s fast-growing data centre industry, the US digital giant has acquired another large property from a well-known agri-business family next to an electricity connection for its power-hungry business.

The US administration’s new pledge to level the playing field on corporation tax is seen as a threat to foreign direct investment in Ireland – but how much of a threat? The Currency’s Stephen Kinsella and Thomas Hubert discuss how to quantify and respond to it.

The US president's plan would "level the playing field" on corporate tax, making it irrelevant to set its rate anywhere below 21 per cent. This is a challenge, but not all bad news for Ireland, as a reading of Microsoft's latest multi-billion profit posting reveals.

As it expands aggressively outside the US, the design-centred social network has a new fashionable item to pin to its board: the green jersey tax structure.

Proponents of international rules to get tech giants to pay tax where their customers are, rather than in hubs like Ireland, have gathered strong momentum in recent weeks.

VMware is first to detail the impact of its IP onshoring to Ireland less than two years ago. The tax benefits are enormous and, like never before, they are laid bare for all to see.

An Irish-designed microchip could have given Intel an edge over Apple and its M1 chip, but instead Intel’s Leixlip operation – and its 4,900 workers – may have an uncertain future in an industry that has become a geopolitical battleground.

Cable and Wireless has just placed its Dublin subsidiary into liquidation. With no employees, the special-purpose vehicle had raised bonds worth $1.4 billion to fund communication networks across the Americas.

Ireland has become a global platform for multinationals to shift profits to low-tax jurisdictions under the form of interest. The resumption of international tax talks following Joe Biden’s election will put this role into question.

Pfizer is highly secretive about releasing details of its vast Irish operation. However, an investigation of over 200 corporate filings made by 80 Pfizer companies in Ireland, Europe and the US reveals $100bn worth of industrial and financial assets located here.